返回ChemicalBook首页>CAS数据库列表>131888-54-5

131888-54-5

中文名称 YM 264
英文名称 YM 264
CAS 131888-54-5
分子式 C24H32N4OS.C4H4O4
分子量 540.681
MOL 文件 131888-54-5.mol
131888-54-5 结构式 131888-54-5 结构式

基本信息

中文别名
化合物 T13369
英文别名
Y-264
YM 264
YM 264,YM264

物理化学性质

储存条件-20°C储存
溶解度溶于二甲基亚砜

常见问题列表

生物活性
YM-264 是一种有口服活性的、血小板活化因子 (PAF) 的有效选择性拮抗剂,其在兔子血小板膜上的 pKi 值为 8.85。
靶点

pKi: 8.85 (PAF, rabbit platelet membranes).

体外研究

The anti-platelet-activating factor effect of YM-264 is examined in vitro. YM-264 inhibits [ 3 H] platelet-activating factor binding to rabbit platelet membranes with a pK i value of 8.85. YM-264 inhibits the platelet-activating factor-induced human, rabbit and guinea-pig platelet aggregation with pA2 values of 8.68, 8.33 and 8.14, respectively.

体内研究

There are no significant differences in baseline airway responsiveness between control and YM-264 treated groups. Airway hyperresponsiveness induced by antigen exposure is significantly inhibited by the administration of YM-264. The baseline Rrs is 0.40 (0.02) cm H 2 O/mL/s in the control group (n=6). In the YM-264 treated groups, the baseline Rrs is 0.39 (0.01) and 0.36 (0.01) cm H 2 O/mL/s at a doses of 1 mg/kg (n=5) and 3 mg/kg (n=6), respectively. The Rrs during the IAR significantly increase from baseline to 0.92 (0.10) cm H 2 O/mL/s in control (p=0.0002), 0.81 (0.12) in YM-264 1 mg/kg (p=0.01), and 1.06 (0.29) in YM-264 3 mg/kg (p=0.048). Reelevation of Rrs in the late phase is observed in the control group after antigen challenge. At this phase, Rrs significantly increase to 0.72 (0.10) cm H 2 O/mL/s (p=0.0101) from the baseline (0.40) at 6 h after the exposure of antigen. In contrast, YM-264 at the doses of 1 and 3 mg/kg show significant inhibition of reelevation of Rrs as compared with control. YM-264 inhibit the eosinophil infiltration dose dependently.

"131888-54-5" 相关产品信息